<?xml version="1.0" encoding="utf-8"?><rss version="2.0"><channel><title>PharmaAsia - Drug Manufacturing</title><link>http://www.pharmaasia.com</link><description>PharmaAsia - Drug Manufacturing</description><language>en-US</language><copyright>Copyright 2012 Ten Alps Communications Asia. All rights reserved.</copyright><pubDate>Thu, 24 May 2012 12:46:08 +0800</pubDate><item><title>Global generic drug markets will grow to US$221 billion by 2016</title><link>http://www.pharmaasia.com/article/global-generic-drug-markets-will-grow-to-us-221-billion-by-2016/9399</link><description>Driven by the need to control costs, the use of generic drugs has grown considerably in recent years, even in markets where traditionally they have not been favored.</description><guid>http://www.pharmaasia.com/article/global-generic-drug-markets-will-grow-to-us-221-billion-by-2016/9399</guid><pubDate>Wed, 23 May 2012 00:00:00 +0800</pubDate></item><item><title>Astellas site implements Werum’s PAS-X</title><link>http://www.pharmaasia.com/article/astellas-site-implements-werum-s-pas-x/9398</link><description>The MES will introduce efficient and state-of-the-art paperless electronic batch recording functionality supporting compliant, efficient and lean production processes.</description><guid>http://www.pharmaasia.com/article/astellas-site-implements-werum-s-pas-x/9398</guid><pubDate>Tue, 22 May 2012 00:00:00 +0800</pubDate></item><item><title>US Supreme Court clears way for generic patent challenges</title><link>http://www.pharmaasia.com/article/us-supreme-court-clears-way-for-generic-patent-challenges/9396</link><description>After the ruling, generic manufacturers will now be able to challenge the content of patent descriptions and, if successful, ultimately force approval of the ANDA. Writing for the Court in a unanimous decision, Justice Elena Kagan chastised the FDA for using ambiguous or opaque guidelines and forms that lend to the confusion surrounding patent decisions.</description><guid>http://www.pharmaasia.com/article/us-supreme-court-clears-way-for-generic-patent-challenges/9396</guid><pubDate>Fri, 18 May 2012 00:00:00 +0800</pubDate></item><item><title>Pharmaceutical giants set to lose dominance in urological disorders market</title><link>http://www.pharmaasia.com/article/pharmaceutical-giants-set-to-lose-dominance-in-urological-disorders-market/9395</link><description>Major pharmaceutical companies are predicted to lose their footing in the urological disorders market by 2017, a report by GBI Research has found.</description><guid>http://www.pharmaasia.com/article/pharmaceutical-giants-set-to-lose-dominance-in-urological-disorders-market/9395</guid><pubDate>Thu, 17 May 2012 00:00:00 +0800</pubDate></item><item><title>Watson in talks to buy Actavis</title><link>http://www.pharmaasia.com/article/watson-in-talks-to-buy-actavis/9391</link><description>Watson Pharmaceuticals is currently in talks to buy private Swiss generic drug maker Actavis.</description><guid>http://www.pharmaasia.com/article/watson-in-talks-to-buy-actavis/9391</guid><pubDate>Fri, 11 May 2012 00:00:00 +0800</pubDate></item><item><title>Kuehne + Nagel launches innovative airfreight solution for pharmaceutical products</title><link>http://www.pharmaasia.com/article/kuehne-nagel-launches-innovative-airfreight-solution-for-pharmaceutical-products/9388</link><description>KN PharmaChain offers – among other features – door-to-door temperature control, a 24 hour alert system, optional wireless temperature measuring and best practice (GxP) standards for facilities, working processes and training programmes.</description><guid>http://www.pharmaasia.com/article/kuehne-nagel-launches-innovative-airfreight-solution-for-pharmaceutical-products/9388</guid><pubDate>Tue, 8 May 2012 00:00:00 +0800</pubDate></item><item><title>More investment needed in anti-obesity drugs</title><link>http://www.pharmaasia.com/article/more-investment-needed-in-anti-obesity-drugs/9384</link><description>Pharmaceutical companies should increase their investment in anti-obesity drug therapies to support the growing number of clinically obese individuals worldwide, a report by GlobalData has found.</description><guid>http://www.pharmaasia.com/article/more-investment-needed-in-anti-obesity-drugs/9384</guid><pubDate>Tue, 1 May 2012 00:00:00 +0800</pubDate></item><item><title>China remains one of the fastest growing pharmaceutical markets in the world</title><link>http://www.pharmaasia.com/article/china-remains-one-of-the-fastest-growing-pharmaceutical-markets-in-the-world/9381</link><description>China and Japan will be the largest and second largest pharmaceutical markets in the Asia Pacific region in 2016.</description><guid>http://www.pharmaasia.com/article/china-remains-one-of-the-fastest-growing-pharmaceutical-markets-in-the-world/9381</guid><pubDate>Fri, 27 Apr 2012 00:00:00 +0800</pubDate></item><item><title>Merck donates five mobile compact labs for detecting counterfeit medicines to Zambia</title><link>http://www.pharmaasia.com/article/merck-donates-five-mobile-compact-labs-for-detecting-counterfeit-medicines-to-zambia/9378</link><description>To help improve health care in Zambia, the Global Pharma Health Fund, a charitable initiative funded by Merck, has donated five mobile compact laboratories to the Health Ministry in the capital city of Lusaka to help detect counterfeit medicines.</description><guid>http://www.pharmaasia.com/article/merck-donates-five-mobile-compact-labs-for-detecting-counterfeit-medicines-to-zambia/9378</guid><pubDate>Tue, 24 Apr 2012 00:00:00 +0800</pubDate></item><item><title>GE Healthcare opens training center in China</title><link>http://www.pharmaasia.com/article/ge-healthcare-opens-training-center-in-china/9374</link><description>GE Healthcare announced the official opening of its expanded Fast Trak Training Center in Shanghai, China.</description><guid>http://www.pharmaasia.com/article/ge-healthcare-opens-training-center-in-china/9374</guid><pubDate>Fri, 20 Apr 2012 00:00:00 +0800</pubDate></item></channel></rss>

